소아청소년 정신과 영역에서 분자유전학적 연구 및 약물 유전학 연구의 최신지견

키워드

참고문헌 (73)

1. State MW, "The Genetics of Childhood Psychiatric Disorders A Decade of Progress", 39(8), pp.946~962 (2000)
2. Barr CL, "Current status of genetic studies of Gilles de la Tourette syndrome", 43(4), pp.351~357 (1998)
3. Falk CT, "an easy reliable way to construct a proper control sample for risk calculations", pp.227~233
4. McGinnis RE, "Transmission test for linkage disequilibrium", pp.506~516
5. Aitman TJ, "Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats", 21, pp.76~83 (1999)
6. Mu JL, "Quantitative trait loci analysis for the differences in susceptibility to atherosclerosis and diabetes between inbred mouse strains C57BL", 6J and C57BLKS, pp.1999, 40[DOI]
7. Faraone SV, "The worldwide prevalence of ADHD: Is it an American condition?", 2, pp.104~ (2003)
8. Faraone SV, "Molecular genetics of attention-deficit", hyperactivity disorder, 2005, pp.57(11), 1313~1323
9. Faraone SV, "Neurobiology of attention-deficit hyperactivity disorder", 44, pp.951~ (1998)
10. Asghari V, "Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants", 5, pp.1157~ (1995)
11. Van Tol HH, "Multiple dopamine D4 receptor variants in the human population", pp.149~
12. Faraone SV, "Meta-analysis of the association between the 7-repeat allele of the dopamine d(4) receptor gene and attention deficit hyperactivity disorder", 158, pp.1052~ (2001)
13. Kim YS, "Family-Based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD", 390(3), pp.176~181 (2005)
14. Spencer T, "Pharmacotherapy of attention deficit hyperactivity disorder", 9, pp.77~ (2000)
15. Pliszka SR, "Catecholamines in attention-deficit", hyperactivity disorder: current perspectives, 1996, pp.35, 264~272
16. Roman T, "Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit hyperactivity disorder?", 120, pp.116~120 (2003)
17. Park L, "Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD", 10, pp.572~580 (2005)
18. Wang B, "Possible association of the alpha-2A adrenergic receptor gene with symptoms of attention-deficit", hyperactivity disorder, 2006, pp.141, 130~134
19. Comings D, "Additive effect of three noradrenergic genes on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects", 55, pp.160~172 (1999)
20. Barr CL, "Attention-deficit hyperactivity disorder and the adrenergic receptors alpha 1C and alpha 2C", 6, pp.334~337 (2001)
21. Beitchman JH, "The serotonin transporter gene in aggressive children with and without ADHD and nonaggressive matched controls", 1008, pp.248~ (2003)
22. Hawi Z, "Serotonergic system and attention deficit hyperactivity disorder (ADHD): A potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample", 7, pp.718~ (2002)
23. Quist JF, "Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD).", 5, pp.537~ (2000)
24. Hess EJ, "Spontaneous locomotor hyperactivity in a mouse mutant with a deletion including the Snap gene on chromosome 2"
25. Choi TK, "Support for the MnlI polymorphism of SNAP25; a Korean ADHD case？Ccontrol study. Mol", 12, pp.224~ (2007)
26. Lowe N, "Joint analysis Of DRD5 marker concludes association with ADHD confined to the predominantly inattentive and combined subtypes", 74, pp.348~ (2004)
27. Comings DE, "The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders", pp.~800
28. Pauls DL, "An update on the genetics of Gilles de la Tourette syndrome", 55, pp.7~ (2003)
29. Grice DE, "Linkage disequilibrium between an allele at the dopamine D4 receptor locus with Tourette’s syndrome by the transmission disequilibrium test", 59, pp.644~ (1996)
30. Heutink P, "Linkage studies on Gilles de la Tourette syndrome: what is the strategy of choice?", 57(2), pp.465~ (1995)
31. Pauls DL, "Progress in the search for genetic linkage with Tourette syndrome an exclusion map covering more than 50% of the autosomal genome"
32. Pauls DL, "Segregation and linkage analyses of Tourette’s syndrome and related disorders"
33. Abelson JF, "Sequence variants in SLITRK1 are associated with Tourette's syndrome", 310(5746), pp.317~320 (2005)
34. Rutter M, "Genetics and child psychiatry: I Advances in quantitative and molecular genetics", 40(1), pp.3~18 (1999)
35. Gupta AR, "Recent Advances in the Genetics of Autism. Biol", 61, pp.429~437 (2007)
36. Alarcon M, "Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families", 7, pp.60~ (2002)
37. Alarcon M, "Quantitative genome scan and Ordered-Subsets Analysis of autism endophenotypes support language QTLs", 10, pp.747~ (2005)
38. McCauley JL, "Genome-wide and Ordered-Subset linkage analyses provide support for autism loci on 17q and 19p with evidence of phenotypic and interlocus genetic correlates", 6, pp.1~ (2005)
39. Lander E, "Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results", 11, pp.241~ (1995)
40. Rabionet R, "Lack of association between autism and SLC25A12", 163, pp.929~ (2006)
41. McCauley JL, "A linkage disequilibrium map of the 1-Mb 15q12 GABA-A receptor subunit cluster and association to autism", 131, pp.51~ (2004)
42. Bacchelli E, "Autism spectrum disorders: Molecular genetic advances", 142C, pp.13~ (2006)
43. Millen KJ, "Abnormal embryonic cerebellar development and patterning of postnatal foliation in two mouse Engrailed-2 mutants"
44. Millen KJ, "A role for En-2 and other murine homologues of Drosophila segment polarity genes in regulating positional information in the developing cerebellum", 121, pp.3935~ (1995)
45. Kuemerle B, "Pattern deformities and cell loss in Engrailed-2 mutant mice suggest two separate patterning events during cerebellar development", 17, pp.7881~ (1997)
46. Benayed R, "Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus", 77, pp.851~ (2005)
47. Weber WW, "Pharmacogenetics" (1997), New York: Oxford Press
48. Meyer UA, "Genomics and the prediction of xenobiotic toxicity", 181(182), pp.463~466 (2002)
49. Philadelphia, "Heredity and the Response to Drugs" (1962)
50. Lerer B, "Pharmaco-genetics of tardive dyskinesia: Combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism", 7, pp.105~ (2002)
51. Li T-K, "Pharmacogenetics of responses to alcohol and genes that influence alcohol drinking", 61, pp.5~ (2000)
52. Spencer T, "Pharmacotherapy of attention deficit hyperactivity disorder across the lifespan", 35, pp.409~ (1996)
53. Wilens T, "ADHD treatment with once-daily OROS methylphenidate Interim 12-month results from a long-term open-label study", 42, pp.424~ (2003)
54. Wilens T, "ADHD treatment with once-daily OROS methylphenidate final results from a long-term open-label study", 44(10), pp.1015~1023 (2005)
55. Winsberg BG, "Association of the dopamine transporter gene (DAT1) with poor methylphenidate response", 38, pp.1474~1477 (1999)
56. Roman T, "Dopamine transporter gene and response to methylphenidate in attention-deficit", hyperactivity disorder, 2002, pp.12, 497~499
57. Rohde LA, "Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit", hyperactivity disorder: a pilot study, 2003, pp.48, 87~89
58. Cheon KA, "The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder Relating to treatment response to methylphenidate", 15(1), pp.95~101 (2005)
59. Stein MA, "Dopamine transporter genotype and methylphenidate dose response in children with ADHD", 30(7), pp.1374~1382 (2005)
60. Langley K, "No support for association between the dopamine transporter (DAT1) gene and ADHD", 139(1), pp.7~10 (2005)
61. van der Meulen EM, "High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD", 46(10), pp.1074~1080 (2005)
62. Seeger G, "Marker gene polymorphism in hyperkinetic disorder- predictors of clinical response to treatment with methylphenidate?", pp.45~48 (2001)
63. Hamarman S, "Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study", 14(4), pp.564~574 (2004)
64. Chang FM, "The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus", 98, pp.91~101 (1996)
65. Lee HJ, "D2 and D4 dopamine receptor gene polymorphisms and personality traits in a young Korean population", 121, pp.44~49 (2003)
66. Lee HJ, "Allelic variants interaction of dopamine receptor D4 polymorphism correlate with personality traits in young Korean female population", 118, pp.76~80 (2003)
67. Ding YC, "Evidence of positive selection acting at the human dopamine receptor D4 gene locus", 99(1), pp.309~314 (2002)
68. Wang E, "The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus", 74(5), pp.931~944 (2004)
69. Asghari V, "Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants", 65(3), pp.1157~1165 (1995)
70. Cheon KA, "Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children", 32(6), pp.1377~1383 (2007)
71. Polanczyk G, "Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit", hyperactivity disorder, 2007, pp.64(2), 218~224
72. McGough J, "Pharmacogenetics of methylphenidate response in preschoolers with ADHD", 45(11), pp.1314~1322 (2006)
73. McGough JJ, "Attention-deficit", hyperactivity disorder. Pharmacogenomics, 2005Jun1, pp.57(11), 1367~1373

관련 논문AI추천